Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01126476 · ClinicalTrials.gov registry record · NA
Proton Radiotherapy for Recurrent Tumors
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT01126476: Completed NA study, sponsored by Abramson Cancer Center at Penn Medicine.
NCT01126476 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01126476, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the feasibility of using proton radiotherapy for reirradiation of recurrent malignancies.
Primary Outcome
To determine if the study is infeasible, defined if greater than 10% of pts experience one of the following: 1. Patient cannot be given treatment because anatomy is such that a dosimetrically satisfactory treatment plan cannot be devised. 2. Patient who receives 15% or more of their treatments (for any reason, i.e. unable to set patient up within acceptable limits of tolerance, patient unable to tolerate treatment position or immobilization for duration of treatment) using photon radiotherapy (
Interventions
- OTHER Proton Radiotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2010-02 |
| Est. Completion | 2020-04 |
| Phase | NA |
What the finished NCT01126476 record still lists
NCT01126476 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Proton Radiotherapy is the first listed.
NCT01126476 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01126476 about?
NCT01126476 is a clinical study titled "Proton Radiotherapy for Recurrent Tumors". The purpose of this study is to determine the feasibility of using proton radiotherapy for reirradiation of recurrent malignancies.
What is the current status of trial NCT01126476?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2010-02. Estimated completion is 2020-04.
What interventions are being tested in trial NCT01126476?
The interventions under investigation include: Proton Radiotherapy (OTHER).
Who is sponsoring clinical trial NCT01126476?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01126476's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia